Dr. Kelly Michele Wilmas, MD

Dr. Wilmas practices at Forefront Dermatology, S.C. in Manitowoc, Wisconsin.

Dr. Wilmas' NPI, 1972008290, was assigned on March 28, 2018. Dr. Wilmas holds Missouri license 2023014180.

Dr. Wilmas' primary practice is Forefront Dermatology, S.C., at 801 York St, Manitowoc, WI 54220 in Manitowoc County. The practice phone is (314) 878-5599.

Dr. Wilmas' primary practice is Forefront Dermatology, S.C. in Manitowoc, Wisconsin. The medical group on file is Forefront Dermatology. Dmand AI also links Dr. Wilmas to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wilmas practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Wilmas' primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Wilmas is licensed in Missouri.

CMS data shows 1,342 Medicare services from Dr. Wilmas across 23 procedure codes in 2024, for 400 Medicare patients. Medicare paid $379,174 for them. Every service was in an office.

CMS counts 400 Medicare patients who saw Dr. Wilmas in 2024. The largest group is 75 to 84, with 165 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wilmas' median patient age at 76, with 43% women.

In 2024, Dr. Wilmas wrote 560 Medicare Part D claims for 356 patients. 99% of them were for generic drugs. CMS names the drug for 500 of them, across 6 drugs with 11 or more claims each, at $3,543 in total drug cost. In 2023, CMS named 40 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Wilmas for performance year 2024, reported as part of a group. Dr. Wilmas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 111 procedures of melanoma (skin cancer) excision by Dr. Wilmas, more than 94% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Dr. Wilmas, published from 2016 to 2023. 2018 was the busiest year, with 3. The most frequent topics are Skin Neoplasms, Biopsy and Carcinoma, Squamous Cell. Dr. Wilmas has published most often in Dermatol Online J. Dr. Wilmas' most frequent co-authors are Sirunya Silapunt, MD, Alexander Brooks Aria, MD and Michael Robert Migden, MD.

CMS Open Payments shows 52 general payments to Dr. Wilmas from 16 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 93% of the total. Organogenesis Inc. paid the most, $380.